The Safety and Immunogenicity of a Trivalent, Live, Attenuated MMR Vaccine, PriorixTM
![]() |
Ahn, Seung-In
(Department of Pediatrics, Han-il General Hospital)
Chung, Min-Kook (Department of Pediatrics, Han-il General Hospital) Yoo, Jung-Suk (Department of Pediatrics, Han-il General Hospital) Chung, Hye-Jeon (Department of Pediatrics, College of Medicine, Kyunghee University) Hur, Jae-Kyun (Department of Pediatrics, St. Paul's Hospital, Catholic Medical College) Shin, Young-Kyu (Department of Pediatrics, Ansan Hospital, College of Medicine, Korea University) Chang, Jin-Keun (Department of Pediatrics, Han-il General Hospital) Cha, Sung-Ho (Department of Pediatrics, College of Medicine, Kyunghee University) |
1 | World Health Organization. Expanded Programme on immunization - accelerated measles strategies. Wkly Epidemiol Rec 1994;69;229-34 |
2 | Koranyi K. Measles(rubeola). In : Rakel RE, Bope ET, editors. Conn's current therapy. Philadelphia : WB Saunders Co, 2002;134-6 |
3 | Gershon A. Mumps. In : Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al. editors. Harrison's principles of internal medicine. 15th ed. New York : McGraw-Hill, 2001:1147-8 |
4 | Miller E, Goldacre M, Pugh S, Coville A, Farrington P, Flower A, et al. Risk of aseptic meningitis after measles, mumps and rubella vaccine in UK children. Lancet 1993; 341:979-82 DOI ScienceOn |
5 | World Health Organization. Vaccines, immunization and biologicals : measles vaccine[online]. [Cited 2003 Apr 10] Available from URL:http://www.who.int/vaccines/en/mumps.shtml. |
6 | World Health Organization. Vaccines, immunization and biologicals : mumps vaccine[online]. [Cited 2003 Apr 10] Available from URL : http//www.who.int/vaccines/en/rubella.shtml. |
7 | World Health Organization. Mumps virus vaccines. Wkly Epidemiol Rec 2001;76:346-55 |
8 | Usonis V, Bakasenas V, Citour K, Clemens R. Comparative study of reactogenecity and immunogenicity of a new measles, mumps and rubella vaccine Priorix and M-M-R II in healthy children. Infection 1998;26:222-6 DOI ScienceOn |
9 | Stocks J, Weibel RE, Villarejos VM, Arguedas JA, Buynak EM, Hilleman MR. Trivalent combined measles-mumpsrubella vaccine. JAMA 1971;218:57-61 DOI ScienceOn |
10 | Hilleman MR. The development of live attenuated mumps virus vaccine in historic perspective and its role in the evolution of combined measles-mumps-rubella. In : Plotkin SA, Fantini B, editors. Vaccinia, vaccination and vaccinology : Jenner, Pasteur and their successors. Paris : Elsevier, 1996:283-92 |
11 | Farrington P, Pugh S, Colville A, Flower A, Nash J, Morgan CP, et al. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/ mumps/rubella vaccines. Lancet 1995;345:567-9 DOI ScienceOn |
12 | World Health Organization. Global measles mortally reduction and regional elimination, 2000-2001. Wkly Epidemiol Rec 2002:77:50-5 |
13 | World Health Organization. WHO-UNICEF joint statement on strategies to reduce measles mortality worldwide. Wkly Epidemiol Rec 2002;77:224-8 |
14 | Peltola H, Heinonen OP, Valle M, Pauno M, Virtanen M, Karanko V, et al. The elimination of indigenous measles, mumps and rubella from Finland by a 12 year, two-dose vaccination program. N Engl J Med 1994;331:1397-402 DOI ScienceOn |
15 | Strebel P, Cochi S, Grabowsky M, Bilous J, Hersh BS, Okweo-Bele JM, et al. The unfinished measles immunization agenda. J Infect Dis 2003;187 Suppl 1:1-7 DOI ScienceOn |
16 | de Quardos CA, Olive JM, Hersh BS, Strassburg MA, Henderson DA, Brandling BD, et al. Measles elimination in the Americas. JAMA 1996;275;224-9. DOI ScienceOn |
17 | Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine : a global review. Bull World Health Organ 1999;77:3-14 |
18 | Christenson B, Bottiger M. Methods for screening the naturally acquired and vaccine-induced immunity to the mumps virus. Biologicals 1990;18:213-9 DOI ScienceOn |
19 | Wellington K, Goa KL. Measles, mumps, rubella vaccine (Priorix TM; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella. Drugs 2003;63:2107-26 DOI ScienceOn |
20 | Balraj V, Miller E. Complications of mumps vaccines. Rev Med Virol 1995;5:219-27 DOI |
21 | Keri W, Kalen LG. Measles, mumps, rubella vaccine(Priorix, GSK-MMR). Drugs 2003;63:2107-2126 DOI ScienceOn |
22 | Kang JH, KIM KH, Sohn YM, Oh SH, Lee HJ, Cha SH, et al. Measles, mumps, rubella. In : Kang JH, editor. Guideline for vaccination. 5th ed. Seoul : The Korea Pediatric Society, 2002:88-115 |
23 | Gershon A, Rubella(German measles). In : Braunwald E. Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al. editors. Harrison's principles of internal medicine. 15th ed. New york : McGraw-Hill, 2001:1145-7 |
24 | World Health Organization. Vaccines, immunization and biologicals : mumps vaccine[online]. [Cited 2003 Apr 10] Available from URL : http//www.who.int/vaccines/en/rubella.shtml. |
25 | Kimura M, Kuno-sakai H, Yamazaki S, Yamada A, Hishiyama M, Kamiya H, et al. Adverse events associated with MMR vaccines in Japan. Acta Pediatrica Japonica 1996;28: 5-11 |
26 | Takcuchi K, Tanabyashi K, Hishiyama M, Yamada A, Surgiura A. Variations of nucleotide sequences and transcription of the SH gene among mumps virus strains. Virology 1991;181:364-6 DOI ScienceOn |
![]() |